News
Valneva has been granted a patent for a method to produce infectious paramyxovirus particles using a specific ... as well as the fusion (F) and matrix (M) proteins from these viruses. The patent also ...
Each had an average of 30-fold more of the insoluble RNA-binding proteins in nuclei than did age- and sex-matched controls (image below). Going Nuclear. In cortical tissue from healthy people (top), ...
Researchers have found that the stability of a protein next to its nuclear localization signal sequence impacts the rate of its entry into the nucleus. Recent research from The Francis Crick Institute ...
The numerous cells that make up mammalian tissues are surrounded by an intricate network of proteins known as the extracellular matrix (ECM). Together, these proteins provide cells with a structural ...
25,34,37,38 Pentraxins also bind to phospholipids and small nuclear ribonucleoproteins ... Extracellular matrix proteins, including fibrinogen and fibronectin, bind microbes and facilitate their ...
It may sound like a blockbuster movie crossover, but researchers are investigating whether so-called matrix proteins could ... "Just imagine if a paramyxovirus emerged that was as contagious ...
Scientists just need a clear view of the paramyxovirus assembly process. The challenge for researchers is trying to see the matrix proteins in action. As the authors noted, “Paramyxoviruses bud ...
Scientists just need a clear view of the paramyxovirus assembly process. The challenge for researchers is trying to see the matrix proteins in action. Capturing viral assembly Norris and his ...
Scientists just need a clear view of the paramyxovirus assembly process. The challenge for researchers is trying to see the matrix proteins in action. Norris and his colleagues examined viral ...
Scientists just need a clear view of the paramyxovirus assembly process. The challenge for researchers is trying to see the matrix proteins in action. Norris and his colleagues examined viral ...
One way to control switching in a protein, such as a nuclear receptor, is to put a drug "in the pocket" of the drug. For her Ph.D. research, Iris van de Gevel looked at controlling two receptors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results